The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The sweet and sour of cancer: glycans as novel therapeutic targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Cell Surface Engineering by a Modified Staudinger Reaction
Saxon, E., & Bertozzi, C. R. (2000) · Science · doi:10.1126/science.287.5460.2007 · Cited by 2,460
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Self-citationHyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
(2011) · Hepatogastroenterology · doi:10.5754/hge11589 · Cited by 1,756
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
STRUCTURAL BASIS OF LECTIN-CARBOHYDRATE RECOGNITION
Weis, W. I., & Drickamer, K. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002301 · Cited by 1,129
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Focal adhesion regulation of cell behavior
Wozniak, M. A., Modzelewska, K., Kwong, L., & Keely, P. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.04.007 · Cited by 999
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori, S. (1996) · PubMed · Cited by 987
Munro, S. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01855-9 · Cited by 957
Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc
Wells, L., Vosseller, K., & Hart, G. W. (2001) · Science · doi:10.1126/science.1058714 · Cited by 954
Molecular diversity of heparan sulfate
Esko, J. D., & Lindahl, U. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13530 · Cited by 951
Self-citationHakomori, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30565-3 · Cited by 879
Chemical remodelling of cell surfaces in living animals
Prescher, J. A., Dube, D. H., & Bertozzi, C. R. (2004) · Nature · doi:10.1038/nature02791 · Cited by 842
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000) · Nature Medicine · doi:10.1038/71429 · Cited by 706
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Suppression of tumor growth and metastasis in Mgat5-deficient mice
Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., & Dennis, J. W. (2000) · Nature Medicine · doi:10.1038/73163 · Cited by 569
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen, S., & Jalkanen, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.3.817 · Cited by 530
Ju, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487
Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena
Iozzo, R. V., & San Antonio, J. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13738 · Cited by 455
P-selectin deficiency attenuates tumor growth and metastasis
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9325 · Cited by 454
Parish, C. R., Freeman, C. G., Brown, K. J., Francis, D. J., & Cowden, W. B. (1999) · PubMed · Cited by 445
Cell adhesion system and human cancer morphogenesis
Hirohashi, S., & Kanai, Y. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01485.x · Cited by 439
Targeting glycosylation as a therapeutic approach
Dwek, R. A., Butters, T. D., Platt, F. M., & Zitzmann, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd708 · Cited by 420
Wang, L., Fuster, M., Sriramarao, P., & Esko, J. D. (2005) · Nature Immunology · doi:10.1038/ni1233 · Cited by 413
Self-citationBorsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261704098 · Cited by 400
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
Tumova, S., Woods, A., & Couchman, J. R. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00116-8 · Cited by 375
(2008) · doi:10.1016/b978-1-4160-3703-3.x5001-7 · Cited by 373
Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Büchler, M. W., Lander, A. D., & Korc, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4105 · Cited by 368
Saoncella, S., Echtermeyer, F., Denhez, F., Nowlen, J. K., Mosher, D. F., Robinson, S. D., Hynes, R. O., & Goetinck, P. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2805 · Cited by 368
Polyamine metabolism and cancer
Thomas, T., & Thomas, T. J. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00210.x · Cited by 332
Takenaka, Y., Fukumori, T., & Raz, A. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014084.01324.15 · Cited by 321
Selectin ligands: will the real ones please stand up?
Varki, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119142 · Cited by 315
Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling
Crocker, P. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00375-5 · Cited by 312
Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.
Bumol, T. F., & Reisfeld, R. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1245 · Cited by 303
Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema, T. R., Couchman, J. R., & McCarthy, J. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.2.521 · Cited by 280
(2002) · PubMed · Cited by 279
Derksen, P. W. B., Keehnen, R. M. J., Evers, L. M., van Oers, M. H. J., Spaargaren, M., & Pals, S. T. (2002) · Blood · doi:10.1182/blood.v99.4.1405 · Cited by 274
Heparan sulfate proteoglycans in invasion and metastasis
Sanderson, R. D. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0241 · Cited by 262
Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer
Lai, J., Chien, J., Staub, J., Avula, R., Greene, E. L., Matthews, T. A., Smith, D. I., Kaufmann, S. H., Roberts, L. R., & Shridhar, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302203200 · Cited by 252
Syndecans in tumor cell adhesion and signaling
Beauvais, D. M., & Rapraeger, A. C. (2004) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-2-3 · Cited by 252
Slovin, S. F., Ragupathi, G., Adluri, S., Ungers, G., Terry, K., Kim, S., Spassova, M., Bornmann, W. G., Fazzari, M., Dantis, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5710 · Cited by 252
Zcharia, E., Metzger, S., Chajek‐Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., Weinstein, T., Li, J., Lindahl, U., & Vlodavsky, I. (2004) · The FASEB Journal · doi:10.1096/fj.03-0572com · Cited by 242
The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells
Beauvais, D. M., Burbach, B. J., & Rapraeger, A. C. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404171 · Cited by 234
Glypicans in growth control and cancer
Filmus, J. (2001) · Glycobiology · doi:10.1093/glycob/11.3.19r · Cited by 226
Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides
Folkman, J., & Shing, Y. (1992) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-2444-5_34 · Cited by 224
Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan
Misra, S., Ghatak, S., Zoltan-Jones, A., & Toole, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300173200 · Cited by 221
Kato, M., Saunders, S., Nguyen, H., & Bernfield, M. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.5.559 · Cited by 217
Ramanathan, R. K., Lee, K. M., McKolanis, J., Hitbold, E., Schraut, W., Moser, A. J., Warnick, E., Whiteside, T., Osborne, J., Kim, H., et al. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0581-1 · Cited by 217
A Novel Glycosulfopeptide Binds to P-selectin and Inhibits Leukocyte Adhesion to P-selectin
Leppänen, A., Mehta, P., Ouyang, Y.-B., Ju, T., Helin, J., Moore, K. L., van Die, I., Canfield, W. M., McEver, R. P., & Cummings, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24838 · Cited by 216
Inhibition of tumor growthin vivo by hyaluronan oligomers
Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J.-W., & Stamenkovic, I. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6 · Cited by 215
Aberrant Glycosylation of E-cadherin Enhances Cell-Cell Binding to Suppress Metastasis
Yoshimura, M., Ihara, Y., Matsuzawa, Y., & Taniguchi, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13811 · Cited by 209
Zhou, Z., Wang, J., Cao, R., Morita, H., Soininen, R., Chan, K. M., Liu, B., Cao, Y., & Tryggvason, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0810 · Cited by 208
Angata, K. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00051-8 · Cited by 205
Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells
Marcum, J. A., & Rosenberg, R. D. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90615-1 · Cited by 203
Woods, A., McCarthy, J. B., Furcht, L. T., & Couchman, J. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.6.605 · Cited by 202
Kojima, N., & Hakomori, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47407-3 · Cited by 196
Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Sharma, B., Handler, M., Eichstetter, I., Whitelock, J. M., Nugent, M. A., & Iozzo, R. V. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3793 · Cited by 194
Пили, Р., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J., & Passaniti, A. (1995) · PubMed · Cited by 194
Pearlstein, E., Salk, P. L., Yogeeswaran, G., & Karpatkin, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4336 · Cited by 192
Nagy, P., Vereb, G., Sebestyén, Z., Horváth, G., Lockett, S. J., Damjanovich, S., Park, J. W., Jovin, T. M., & Szöllősi, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00118 · Cited by 190
Seidenfaden, R., Krauter, A., Schertzinger, F., Gerardy-Schahn, R., & Hildebrandt, H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5908-5918.2003 · Cited by 190
Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
Miyamoto, S., Hirata, M., Yamazaki, A., Kageyama, T., Hasuwa, H., Mizushima, H., Tanaka, Y., Yagi, H., Sonoda, K., Kai, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0811 · Cited by 185
MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., & Gendler, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206291 · Cited by 173
The joys of HexNAc. The synthesis and function of N-andO-glycan branches
Schachter, H. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011010206774 · Cited by 170
Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky, I., Mohsen, M., Lider, O., Cm, S., Hp, E., Vigoda, M., Ishai-Michaeli, R., & Peretz, T. (1994) · PubMed · Cited by 170
Cell Surface α2,6-Sialylation Affects Adhesion of Breast Carcinoma Cells
Lin, S., Kemmner, W., Grigull, S., & Schlag, P. M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5521 · Cited by 168
Brinkman-Van der Linden, E. C. M., & Varki, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8625 · Cited by 168
Goldshmidt, O., Zcharia, E., Abramovitch, R., Metzger, S., Aingorn, H., Friedmann, Y., Schirrmacher, V., Mitrani, E., & Vlodavsky, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152070599 · Cited by 164
Manne, U., Myers, R. B., Moron, C., Poczatek, R. B., Dillard, S. C., Weiss, H. L., Brown, D., Srivastava, S., & Grizzle, W. E. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<296::aid-ijc11>3.0.co;2-a · Cited by 163
Varki, N. M., & Varki, A. (2002) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2002-20564 · Cited by 163
Simpson, M. A., Wilson, C. M., & McCarthy, J. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64245-9 · Cited by 160
Gutheil, J. C. (1996) · JAMA · doi:10.1001/jama.1996.03530300076049 · Cited by 151
The cancer antigen CA125 represents a novel counter receptor for galectin-1
Seelenmeyer, C., Wegehingel, S., Lechner, J., & Nickel, W. (2003) · Journal of Cell Science · doi:10.1242/jcs.00312 · Cited by 144
Fukuda, M., Οhyama, C., Lowitz, K., Matsuo, O., Pasqualini, R., Ruoslahti, E. I., & Fukuda, M. (2000) · PubMed · Cited by 144
Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.
Fritz, T. A., Lugemwa, F. N., Sarkar, A. K., & Esko, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42349-0 · Cited by 140
Self-citationLapierre, F., Holme, K. R., Lam, L. H., Tressler, R., Storm, N., Wee, J., Stack, R. J., Castellot, J. J., & Tyrrell, D. J. (1996) · Glycobiology · doi:10.1093/glycob/6.3.355 · Cited by 139
Involvement of carbohydrate antigen sialyl Lewisx in colorectal cancer metastasis
Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Izumi, Y., & Irimura, T. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02258386 · Cited by 137
Perlecan and Tumor Angiogenesis
Jiang, X., & Couchman, J. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305101101 · Cited by 135
Expanding the Diversity of Unnatural Cell‐Surface Sialic Acids
Luchansky, S. J., Goon, S., & Bertozzi, C. R. (2004) · ChemBioChem · doi:10.1002/cbic.200300789 · Cited by 134
Lee, C. M., Tanaka, T. T., Murai, T., Kondo, M., Kimura, J., Su, W., Kitagawa, T., Ito, T., Matsuda, H., & Miyasaka, M. (2002) · PubMed · Cited by 132
A phase I study of swainsonine in patients with advanced malignancies.
Goss, P. E., Baptiste, J., Fernandes, B., Baker, M., & Dennis, J. W. (1994) · PubMed · Cited by 128
Glithero, A., Tormo, J., Haurum, J. S., Arsequell, G., Valencia, G., Edwards, J. H., Springer, S., Townsend, A., Pao, Y., Wormald, M. R., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80007-2 · Cited by 123
Tumor attenuation by combined heparan sulfate and polyamine depletion
Belting, M., Borsig, L., Fuster, M. M., Brown, J. R., Persson, L., Fransson, L., & Esko, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012346499 · Cited by 120
Self-citationA disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
Fuster, M. M., Brown, J. R., Wang, L., & Esko, J. D. (2003) · PubMed · Cited by 112
Self-citationNoujaim, A. A., Schultes, B. C., Baum, R. P., et al. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152389384 · Cited by 110
Pagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., & Ponzoni, M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.253 · Cited by 106
Ragupathi, G., Livingston, P. O., Hood, C., Gathuru, J., Krown, S. E., Chapman, P. B., Wolchok, J. D., Williams, L. J., Oldfield, R. C., & Hwu, W. (2003) · PubMed · Cited by 103
Heparin Derivatives as Angiogenesis Inhibitors
Presta, M., Leali, D., Stabile, H., Ronca, R., Camozzi, M., Coco, L., Moroni, E., Liekens, S., & Rusnati, M. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391379 · Cited by 103
Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs
Jemth, P., Kreuger, J., Kusche‐Gullberg, M., Sturiale, L., Giménez‐Gallego, G., & Lindahl, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203404200 · Cited by 102
The role of integrins in tumor angiogenesis
Hwang, R. F., & Varner, J. A. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.09.010 · Cited by 101
Liekens, S., Leali, D., Neyts, J. H., Esnouf, R. M., Rusnati, M., Dell’Era, P., Maudgal, P. C., Clercq, E. D., & Presta, M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.204 · Cited by 98
Arrays for the Combinatorial Exploration of Cell Adhesion
Orner, B. P., Derda, R., Lewis, R. L., Thomson, J. A., & Kiessling, L. L. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0474291 · Cited by 97
Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine
Carr, A., Rodríguez, E., Arango, M. D. C., Camacho, R., Osorio, M., Gabri, M. R., Carrillo, G., del Pozo, Z. V., Bebelagua, Y., Pérez, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.124 · Cited by 97
Design and synthesis of sialyl Lewisx mimics as E‐ and P‐selectin inhibitors
Kaila, N., & Thomas, B. E. (2002) · Medicinal Research Reviews · doi:10.1002/med.10018 · Cited by 96
Dennis, J. W., Pawling, J., Cheung, P., Partridge, E. A., & Demetriou, M. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00411-7 · Cited by 94
Fucosylation of Disaccharide Precursors of Sialyl LewisX Inhibit Selectin-mediated Cell Adhesion
Sarkar, A. K., Rostand, K. S., Jain, R. K., Matta, K. L., & Esko, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25608 · Cited by 92
Self-citationCell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion
Iida, J., Meijne, A. M. L., Knutson, J. R., Furcht, L. T., & McCarthy, J. B. (1996) · Seminars in Cancer Biology · doi:10.1006/scbi.1996.0021 · Cited by 91
DeBaun, M. R., Ess, J., & Saunders, S. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3150 · Cited by 88
Dynamic Regulation of Tumor Growth and Metastasis by Heparan Sulfate Glycosaminoglycans
Liu, D., Shriver, Z. H., Qi, Y., Venkataraman, G., & Sasisekharan, R. (2002) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2002-20565 · Cited by 86
Mechanisms of Ganglioside Inhibition of APC Function
Caldwell, S. A., Heitger, A., Shen, W., Liu, Y., Taylor, B. J., & Ladisch, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1676 · Cited by 84
Julien, S., Krzewinski‐Recchi, M., Harduin‐Lepers, A., Gouyer, V., Huet, G., Bourhis, X. L., & Delannoy, P. (2001) · Glycoconjugate Journal · doi:10.1023/a:1022200525695 · Cited by 83
L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis
Qian, F., Hanahan, D., & Weissman, I. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061633698 · Cited by 80
Reversibility of oncogene-induced cancer
Felsher, D. W. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.12.008 · Cited by 78
Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1
Musselli, C., Ragupathi, G., Gilewski, T. A., Panageas, K. S., Spinat, Y., & Livingston, P. O. (2001) · International Journal of Cancer · doi:10.1002/ijc.10081 · Cited by 77
Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase.
Weiss, M., Hettmer, S., Smith, P., & Ladisch, S. (2003) · PubMed · Cited by 77
O-Linked N-Acetylglucosamine and Cancer: Messages from the Glycosylation of C-Myc
Chou, T., & Hart, G. W. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1267-7_26 · Cited by 74
Autocrine signaling in carcinoma: VEGF and the α6β4 integrin
Mercurio, A. M., Bachelder, R. E., Bates, R. C., & Chung, J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.016 · Cited by 73
Targeting Pdgf Receptors in Cancer Rationales and Proof of Concept Clinical Trials
George, D. J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_12 · Cited by 71
Zcharia, E., Metzger, S., Chajek-Shaul, T., et al. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011375624902 · Cited by 70
Gangliosides inhibit the development from monocytes to dendritic cells
Wölfl, M., Batten, W. Y., Posovszky, C., Bernhard, H., & Berthold, F. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.02006.x · Cited by 64
Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA
Adatia, R., Albini, A., Carlone, S., Giunciuglio, D., Benelli, R., Santi, L., & Noonan, D. M. (1997) · Annals of Oncology · doi:10.1023/a:1008243115385 · Cited by 64
Nguyen, M. T. N., Folkman, J., & Bischoff, J. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35730-2 · Cited by 63
Kleeff, J. H., Wildi, S., Kumbasar, A., Frieß, H., Lander, A. D., & Korc, M. (1999) · Pancreas · doi:10.1097/00006676-199910000-00009 · Cited by 62
Brown, J. R., Fuster, M. M., Whisenant, T. C., & Esko, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303093200 · Cited by 51
Self-citationSelective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids
Horstkorte, R., Mühlenhoff, M., Reutter, W. G., Nöhring, S., Zimmermann‐Kordmann, M., & Gerardy‐Schahn, R. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.014 · Cited by 51
Nutt, C. L., Zerillo, C. A., Kelly, G. M., & Hockfield, S. J. (2001) · PubMed · Cited by 46
Clinical Development of the STn-KLH Vaccine (Theratope®)
Ibrahim, N. K., & Murray, J. L. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.s.003 · Cited by 44
Syrokou, A., Tzanakakis, G. N., Hjerpe, A., & Karamanos, N. K. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80131-x · Cited by 41
Holmberg, L., Oparin, D., Gooley, T. A., & Sandmaier, B. M. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.s.004 · Cited by 35
Cancer Metastasis: A Search for Therapeutic Inhibition
Dimitroff, C. J., Sharma, A., & Bernacki, R. J. (1998) · Cancer Investigation · doi:10.3109/07357909809039778 · Cited by 32
An expanding role for antithrombotic therapy in cancer patients
Kakkar, A. K. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)80006-3 · Cited by 23
Hayashi, N., Nakamori, S., Okami, J., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Narimatsu, H., & Monden, M. (2003) · Pathobiology · doi:10.1159/000072959 · Cited by 17
Analysis of Diffrentiation and Transformation of Cells by Lectins
Raedler, A., Schreiber, S., & Batsakis, J. G. (1988) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368809106861 · Cited by 14
Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments
Bestagno, M., Occhino, M., Corrias, M. V., Burrone, Ó. R., & Pistoia, V. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00109-5 · Cited by 9
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Self-citation
Metadata
- Authors
- Fuster, M. M., & Esko, J. D.
- Venue
- Nature Reviews Cancer
- Published
- 2005-07
- Volume
- 5
- Issue
- 7
- Pages
- 526-542
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2059529313
- Cited by
- 1,383
- References
- 133
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.